SILICON LABORATORIES INC.
For the period ended Jul 4, 2026. Filed Aug 11, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 4, 2026 · Filed Aug 11, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Arrangements
The following table describes contracts, instructions, or written plans for the purchase or sale of our securities by our directors and officers (as defined under Rule 16b-1(f) of the Exchange Act) intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into or terminated during the quarter ended July 4, 2026. There were no non-Rule 10b5-1 trading arrangements entered into orterminated during the quarter ended July 4, 2026.
| Name and Title of Director or Officer | Action | Date of Adoption or Termination of Arrangement | Expiration Date | Aggregate Number of Securities to be Purchased or Sold Pursuant to the Arrangement |
|---|---|---|---|---|
| Bob ConradSenior Vice President and General Manager | Adoption | May 7, 2026 | May 28, 2027 | 31,344 |
| Navdeep SoochDirector | Termination(1) | May 6, 2026 | May 21, 2026 | 45,000 |
| Brandon TolanySenior Vice President Worldwide Sales, Marketing, and Applications | Termination(2) | February 13, 2026(2) | September 1, 2026 | 16,200 |
(1) Trading arrangement previously adopted on May 22, 2024.
(2) Trading arrangement previously adopted on August 29, 2025. The termination was inadvertently omitted from our Quarterly Report on Form 10-Q for the quarter ended April 4, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.